Literature DB >> 2625091

Risk factors for ocular sarcoidosis.

A Rothova1, C Alberts, E Glasius, A Kijlstra, H J Buitenhuis, A C Breebaart.   

Abstract

We reviewed 121 consecutive patients with biopsy-proven sarcoidosis who visited the sarcoidosis clinic of the University Hospital in Amsterdam, to determine the risk factors for the development of ocular manifestations. Of 121 patients 52 (43%) were black. Ocular disease developed in 50 (41%) patients and was more common in female and in black patients. uveitis was the most frequent manifestation of ocular sarcoidosis (29 out of 50 or 58%). There were no differences in the extra-ocular manifestations of the sarcoidosis between patients with and without ocular disease or between uveitis and non-uveitis patients. This study covered a mixed racial population and shows that different types of uveitis are seen in white and black patients. Anterior uveitis was more frequent in black patients (P less than .001), whereas posterior uveitis was more common in white patients (P less than .01). Chronic posterior uveitis with complications occurred most frequently in white female patients with late onset of the systemic disease. Uveitis was an early feature of sarcoidosis (25 out of 29 or 86%); moreover in 9 out of 29 (31%) cases, uveitis preceded the non-ocular detectable signs of sarcoidosis by more than one year. This emphasizes the importance of periodic re-evaluation of uveitis patients for sarcoidosis.

Entities:  

Mesh:

Year:  1989        PMID: 2625091     DOI: 10.1007/bf00153496

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  16 in total

1.  THE EYES IN SARCOIDOSIS.

Authors:  R P Crick; C Hoyle; H Smellie
Journal:  Br J Ophthalmol       Date:  1961-07       Impact factor: 4.638

2.  Changing patterns of uveitis.

Authors:  D E Henderly; A J Genstler; R E Smith; N A Rao
Journal:  Am J Ophthalmol       Date:  1987-02-15       Impact factor: 5.258

3.  Sixteen cases of uveitis associated with sarcoidosis.

Authors:  M F Bienfait; G S Baarsma
Journal:  Int Ophthalmol       Date:  1986-12       Impact factor: 2.031

4.  Course and prognosis of sarcoidosis around the world.

Authors:  L E Siltzbach; D G James; E Neville; J Turiaf; J P Battesti; O P Sharma; Y Hosoda; R Mikami; M Odaka
Journal:  Am J Med       Date:  1974-12       Impact factor: 4.965

5.  Lacrimal gland uptake of gallium citrate Ga 67.

Authors:  R N Weinreb; E Q Yavitz; G R O'Connor; R A Barth
Journal:  Am J Ophthalmol       Date:  1981-07       Impact factor: 5.258

6.  Uveitis. A series of 368 patients.

Authors:  D G James; A I Friedmann; E Graham
Journal:  Trans Ophthalmol Soc U K       Date:  1976-04

7.  Uveitis: aetiology and disease associations in an Australian population.

Authors:  D Wakefield; I Dunlop; P J McCluskey; R Penny
Journal:  Aust N Z J Ophthalmol       Date:  1986-08

8.  Computer registration of uveitis patients.

Authors:  A Kijlstra; A Rothova; G S Baarsma; M J Zaal; M E Fortuin; C Schweitzer; E Glasius; P T de Jong
Journal:  Doc Ophthalmol       Date:  1987 Sep-Oct       Impact factor: 2.379

9.  Assessment of activity of ocular sarcoidosis by gallium scanning.

Authors:  A Karma; A A Poukkula; A O Ruokonen
Journal:  Br J Ophthalmol       Date:  1987-05       Impact factor: 4.638

10.  Sarcoidosis and its ophthalmic manifestations.

Authors:  C D Obenauf; H E Shaw; C F Sydnor; G K Klintworth
Journal:  Am J Ophthalmol       Date:  1978-11       Impact factor: 5.258

View more
  28 in total

Review 1.  Ocular involvement in sarcoidosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

Review 2.  Ocular Sarcoidosis.

Authors:  Sirichai Pasadhika; James T Rosenbaum
Journal:  Clin Chest Med       Date:  2015-12       Impact factor: 2.878

3.  Cigarette smoking and male sex are independent and age concomitant risk factors for the development of ocular sarcoidosis in a New Orleans sarcoidosis population.

Authors:  Adam C Janot; Dörte Huscher; McCall Walker; Harmonjot K Grewal; Mary Yu; Matthew R Lammi; Lesley Ann Saketkoo
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2015-07-22       Impact factor: 0.670

4.  Serpiginous choroiditis: an unusual presentation of ocular sarcoidosis.

Authors:  C Edelsten; M R Stanford; E M Graham
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

Review 5.  The possible impact of uveitis in blindness: a literature survey.

Authors:  M S Suttorp-Schulten; A Rothova
Journal:  Br J Ophthalmol       Date:  1996-09       Impact factor: 4.638

6.  Diagnostic yield of vitreous biopsy in presumed sarcoidosis-related posterior segment inflammation.

Authors:  Adrienne W Scott; Prithvi Mruthyunjaya; Rex M McCallum; Glenn J Jaffe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-21       Impact factor: 3.117

Review 7.  Ocular sarcoidosis: new diagnostic modalities and treatment.

Authors:  Sung J Yang; Sherveen Salek; James T Rosenbaum
Journal:  Curr Opin Pulm Med       Date:  2017-09       Impact factor: 3.155

8.  Cistoid macular edema as first manifestation of sarcoidosis.

Authors:  Lucia Cabrillo-Estevez; Lourdes de Juan-Marcos; Danai Kyriakou; Emiliano Hernández-Galilea
Journal:  Int Ophthalmol       Date:  2013-12-10       Impact factor: 2.031

9.  Diagnostic management of patients with suspected ocular sarcoidosis.

Authors:  Kazuto Takada; Shuuichi Matsumoto; Eiji Kojima; Susumu Iwata; Kentarou Tanaka
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

Review 10.  Elderly-onset sarcoidosis: prevalence, clinical course, and treatment.

Authors:  Yvan Jamilloux; Marc Bonnefoy; Dominique Valeyre; Loig Varron; Christiane Broussolle; Pascal Sève
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.